2016 PREVIEW: China - Three Regulatory Trends To Watch
This article was originally published in PharmAsia News
Executive Summary
The year of 2015 in the China pharma market was marked by a drastic market slowdown and turbulent regulatory headwinds. But looking ahead, analysts say that while many challenges remain, some important breakthroughs could be on the way.